John A. Zuris

9.0k total citations · 3 hit papers
24 papers, 6.4k citations indexed

About

John A. Zuris is a scholar working on Molecular Biology, Renewable Energy, Sustainability and the Environment and Inorganic Chemistry. According to data from OpenAlex, John A. Zuris has authored 24 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Renewable Energy, Sustainability and the Environment and 5 papers in Inorganic Chemistry. Recurrent topics in John A. Zuris's work include CRISPR and Genetic Engineering (10 papers), Metalloenzymes and iron-sulfur proteins (10 papers) and Metal-Catalyzed Oxygenation Mechanisms (5 papers). John A. Zuris is often cited by papers focused on CRISPR and Genetic Engineering (10 papers), Metalloenzymes and iron-sulfur proteins (10 papers) and Metal-Catalyzed Oxygenation Mechanisms (5 papers). John A. Zuris collaborates with scholars based in United States, Israel and Sweden. John A. Zuris's co-authors include David R. Liu, Alexis C. Komor, Michael S. Packer, David B. Thompson, John P. Guilinger, J. Keith Joung, Zheng‐Yi Chen, Yilai Shu, Johnny H. Hu and Morgan L. Maeder and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

John A. Zuris

22 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

2016 3.6k citations Alexis C. Komor, Michael S. Packer et al. Nature profile →
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

2014 1.2k citations John A. Zuris, David B. Thompson et al. Nature Biotechnology profile →
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles

2016 540 citations Ming Wang, John A. Zuris et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by John A. Zuris

Since Specialization

Citations

This map shows the geographic impact of John A. Zuris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Zuris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Zuris more than expected).

Fields of papers citing papers by John A. Zuris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Zuris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Zuris. The network helps show where John A. Zuris may publish in the future.

Co-authorship network of co-authors of John A. Zuris

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Zuris. A scholar is included among the top collaborators of John A. Zuris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Zuris. John A. Zuris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT 2025 ·Molecular Therapy ·Eugenio Marco, Patricia Sousa, (unknown), (unknown), Jack Heath, Ramya Viswanathan, John A. Zuris, Gregory Gotta, Georgia Giannoukos, Scott D. Hansen, David K. Wood, Mark C. Walters, John F. Tisdale, Christopher J. Wilson, Kai‐Hsin Chang	0
2	Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo 2023 ·Nature Communications ·Yong Tao, Verónica Lamas, Wan Du, Wenliang Zhu, Yiran Li, Madelynn N. Whittaker, John A. Zuris, David B. Thompson, Arun Prabhu Rameshbabu, Yilai Shu, Xue Gao, Johnny H. Hu, (unknown), Weijia Kong, Xuezhong Liu, Hao Wu, Benjamin P. Kleinstiver, David R. Liu, Zheng‐Yi Chen	29
3	Detection and Modulation of DNA Translocations During Multi-Gene Genome Editing in T Cells 2020 ·The CRISPR Journal ·Anne Bothmer, (unknown), (unknown), Frank A. Buquicchio, Lucas Cohen, Ramya Viswanathan, John A. Zuris, Eugenio Marco, Cecilia A. Fernández, Vic E. Myer, Cecilia Cotta‐Ramusino	34
4	EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD 2019 ·Blood ·(unknown), Jack Heath, John A. Zuris, Patricia Sousa, Ramya Viswanathan, (unknown), (unknown), (unknown), (unknown), Tongyao Wang, Cecilia Fernández, Vic E. Myer, Charles F. Albright, Christopher J. Wilson, (unknown), Kai‐Hsin Chang	23
5	Expanding CRISPR Genome Editing Strategies in Hematopoietic Stem and Progenitor Cells for the Treatment of Hematologic Diseases 2017 ·Blood ·(unknown), (unknown), Jack Heath, Carrie M. Margulies, (unknown), Ramya Viswanathan, (unknown), Kai‐Hsin Chang, Hariharan Jayaram, John A. Zuris, Vic E. Myer, (unknown), Cecilia Cotta‐Ramusino, Jennifer L. Gori	1
6	Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles breakdown → 2016 ·Proceedings of the National Academy of Sciences ·Ming Wang, John A. Zuris, Fantao Meng, Holly A. Rees, Shuo Sun, Pu Deng, Yong Han, Xue Gao, Dimitra Pouli, Qi Wu, Irene Georgakoudi, David R. Liu, Qiaobing Xu	540
7	Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage breakdown → 2016 ·Nature ·Alexis C. Komor, (unknown), Michael S. Packer, John A. Zuris, David R. Liu	3599
8	Small molecule–triggered Cas9 protein with improved genome-editing specificity 2015 ·Nature Chemical Biology ·(unknown), Vikram Pattanayak, David B. Thompson, John A. Zuris, David R. Liu	340
9	Continuous directed evolution of DNA-binding proteins to improve TALEN specificity 2015 ·Nature Methods ·Basil P. Hubbard, Ahmed H. Badran, John A. Zuris, John P. Guilinger, (unknown), Liwei Chen, Shengdar Q. Tsai, Jeffry D. Sander, J. Keith Joung, David R. Liu	89
10	Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo breakdown → 2014 ·Nature Biotechnology ·John A. Zuris, David B. Thompson, Yilai Shu, John P. Guilinger, (unknown), Johnny H. Hu, Morgan L. Maeder, J. Keith Joung, Zheng‐Yi Chen, David R. Liu	1160
11	Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1 2014 ·Proceedings of the National Academy of Sciences ·Sagi Tamir, Shahar Rotem‐Bamberger, Chen Katz, Faruck Morcos, (unknown), John A. Zuris, Charles Wang, Andrea R. Conlan, Colin H. Lipper, Mark L. Paddock, Ron Mittler, José N. Onuchic, Patricia A. Jennings, Assaf Friedler, Rachel Nechushtai	54
12	Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic Drugs 2013 ·PLoS ONE ·Sagi Tamir, John A. Zuris, (unknown), Colin H. Lipper, Andrea R. Conlan, Dorit Michaeli, Yael Harir, Mark L. Paddock, Ron Mittler, Z. Ioav Cabantchik, Patricia A. Jennings, Rachel Nechushtai	42
13	Allosteric control in a metalloprotein dramatically alters function 2012 ·Proceedings of the National Academy of Sciences ·E.L. Baxter, John A. Zuris, Charles Wang, (unknown), Herbert L. Axelrod, Aina E. Cohen, Mark L. Paddock, Rachel Nechushtai, José N. Onuchic, Patricia A. Jennings	23
14	NADPH Inhibits [2Fe-2S] Cluster Protein Transfer from Diabetes Drug Target MitoNEET to an Apo-acceptor Protein 2012 ·Journal of Biological Chemistry ·John A. Zuris, (unknown), Howard Yeh, (unknown), Rachel Nechushtai, Mark L. Paddock, Patricia A. Jennings	26
15	Characterization of Arabidopsis NEET Reveals an Ancient Role for NEET Proteins in Iron Metabolism 2012 ·The Plant Cell ·Rachel Nechushtai, Andrea R. Conlan, Yael Harir, Luhua Song, Ohad Yogev, Y. Eisenberg-Domovich, Oded Livnah, Dorit Michaeli, Rachel Rosen, T. Vincent, Yuting Luo, John A. Zuris, Mark L. Paddock, Z. Ioav Cabantchik, Patricia A. Jennings, Ron Mittler	87
16	Mutation of the His ligand in mitoNEET stabilizes the 2Fe–2S cluster despite conformational heterogeneity in the ligand environment 2011 ·Acta Crystallographica Section D Biological Crystallography ·Andrea R. Conlan, Mark L. Paddock, Christina M. Homer, Herbert L. Axelrod, Aina E. Cohen, Edward C. Abresch, John A. Zuris, Rachel Nechushtai, Patricia A. Jennings	23
17	Allostery in the ferredoxin protein motif does not involve a conformational switch 2011 ·Proceedings of the National Academy of Sciences ·Rachel Nechushtai, Heiko Lammert, Dorit Michaeli, Y. Eisenberg-Domovich, John A. Zuris, Maria Antonietta De Luca, Dominique T. Capraro, (unknown), (unknown), M. Roy, Alexander Schug, Paul C. Whitford, Oded Livnah, José N. Onuchic, Patricia A. Jennings	28
18	Redox Potential of the Outer-Mitochondrial Membrane 2Fe-2S Protein MitoNEET 2009 ·Biophysical Journal ·John A. Zuris, Mark L. Paddock, Edward C. Abresch, Andrea R. Conlan, Rachel Nechushtai, Patricia A. Jennings	4
19	Crystal Structure of Miner1: The Redox-active 2Fe-2S Protein Causative in Wolfram Syndrome 2 2009 ·Journal of Molecular Biology ·Andrea R. Conlan, Herbert L. Axelrod, Aina E. Cohen, Edward C. Abresch, John A. Zuris, David P. Yee, Rachel Nechushtai, Patricia A. Jennings, Mark L. Paddock	104
20	Redox Characterization of the FeS Protein MitoNEET and Impact of Thiazolidinedione Drug Binding 2009 ·Biochemistry ·Daniel W. Bak, John A. Zuris, Mark L. Paddock, Patricia A. Jennings, Sean J. Elliott	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact